Dutasteride: Scientific Profile
Publicado el · Actualizado el
Dutasteride is a selective dual inhibitor of the 5-alpha reductase type 1 and type 2 isoenzymes. Its application in research models focuses on the systemic reduction of dihydrotestosterone (DHT).
Dutasteride is a synthetic compound of the 4-azasteroid class with high affinity for the enzyme 5-alpha reductase. Unlike other inhibitors that act only on the type 2 isoenzyme, this agent competitively inhibits both the type 1 and the type 2 isoenzymes, which are responsible for the conversion of testosterone into 5-alpha-dihydrotestosterone (DHT), the main androgenic ligand in tissues such as the prostate and the scalp. In experimental models, dual inhibition results in a suppression of serum DHT levels greater than 90%, which allows the study of androgen-dependent processes with significantly greater efficacy than mono-specific inhibitors.
In histological and molecular research settings, Dutasteride is used to evaluate cellular proliferation in androgen-dependent tissues. The drastic reduction of DHT facilitates the analysis of the involution of glandular tissues and the dynamics of hair follicles in models of androgenic alopecia. Its pharmacokinetics are characterized by a long half-life, which allows observation of persistent effects on the modulation of the hormonal axis after administration in study subjects.
Beyond its impact on follicular and glandular health, research with Dutasteride encompasses the exploration of its influence on lipid metabolism and steroid-receptor signaling. Given its irreversible-inhibitor profile, this compound is fundamental in laboratory protocols that require a near-total neutralization of the 5-alpha reductase pathway in order to isolate specific androgenic variables.
Mechanism of action
It acts as a competitive and irreversible inhibitor of the enzyme 5-alpha reductase. It binds covalently to the type 1 (dominant in skin and sebaceous glands) and type 2 (dominant in reproductive tissues and hair follicle) isoforms, blocking the reduction of the double bond between carbon 4 and 5 of the steroid ring of testosterone, thereby preventing the biosynthesis of dihydrotestosterone.
Mechanism summary
Dual inhibitor of isoenzymes 1 and 2 of 5α-reductase, drastically reducing the conversion of testosterone to dihydrotestosterone in peripheral tissues.
Clinical Studies (7)
- Topical dutasteride for androgenic alopecia: current state and prospects (Andrade JFM et al. · Therapeutic delivery · 2025) PMID 39641480.
- Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia (Gupta AK et al. · The Journal of dermatological treatment · 2022) PMID 35920739.
- Dutasteride in Androgenetic Alopecia: An Update (Arif T et al. · Current clinical pharmacology · 2017) PMID 28294070.
- Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. (Lee S, et al. · Acta Derm Venereol · 2019) PMID 30206635.
- The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. (Zhou Z, et al. · Clin Interv Aging · 2019) PMID 30863034.
- Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. (Clark RV, et al. · J Clin Endocrinol Metab · 2004) PMID 15126539.
- The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men. (Amory JK, et al. · J Urol · 2008) PMID 18423697.
Warnings
Dutasteride is a research-use-only (RUO) compound; the following warnings and handling considerations apply to its laboratory use:
- Substance of restricted handling; requires personal protective equipment
- Risk of transdermal absorption in laboratory personnel
- Teratogenicity confirmed in research models
- For exclusive use in in vitro experimentation or animal models
- Interaction with gestation models due to risk of fetal feminization
- Study subjects with severe hepatic dysfunction
- Known hypersensitivity to 5-alpha reductase inhibitors
- Co-investigation with compounds that require DHT for their bioactivity
Technical data
- CAS
- 164656-23-9
- Molecular formula
- C27H30F6N2O2
- Molecular weight
- 528.5 Da
- Compound type
- metabolic
- Storage
- 15-30°C
- Shelf life (lyophilized)
- 36 months
- Shelf life (reconstituted)
- Not applicable (Solid presentation)
- Light-sensitive
- No
Frequently asked questions about Dutasteride
What is Dutasteride?
Dutasteride is a selective dual inhibitor of the 5-alpha reductase type 1 and type 2 isoenzymes. Its application in research models focuses on the systemic reduction of dihydrotestosterone (DHT).
What is the mechanism of action of Dutasteride?
Dual inhibitor of isoenzymes 1 and 2 of 5α-reductase, drastically reducing the conversion of testosterone to dihydrotestosterone in peripheral tissues.
What is Dutasteride researched for?
In preclinical research, Dutasteride is studied mainly in: Research on the inhibition of hair follicle miniaturization; Study of the modulation of DHT levels in glandular tissues; Analysis of androgen-dependent tissue involution. Material exclusively for scientific research.
What are the chemical properties of Dutasteride?
Molecular formula C27H30F6N2O2; molecular weight 528.5 Da; CAS number 164656-23-9.
How is Dutasteride stored?
Storage conditions: 15-30°C; lyophilized stability: 36 months; once reconstituted: Not applicable (Solid presentation).
What routes of administration are studied for Dutasteride?
In research models the following are described: Oral, Topical (Cutaneous research). Use is exclusively for scientific research.